GSK opts for BioClinica IVR system across trials

GlaxoSmithKline ($GSK) has selected BioClinica's Trident interactive web response system for use across Phase I through IV trials. The drug giant wants internal staff to be able to set up and manage studies, including the randomization and supply functions. Trident also provides interactive voice response phone support. BioClinica release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.